Clinical Trial Update: Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

View source ↗

Summary

This completed clinical trial evaluated Ax-003/Arimidex (anastrozole) as adjuvant therapy for early breast cancer. The study investigated the use of arimidex in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED